Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Robbing Peter to pay Paul

Article Abstract:

A biotech company's decision to buy back its own shares is like a decision to invest cash presently to buy back shares that may be worth more in the future, when the company can reissue the same share for more money. The action is similar to that of 'robbing Peter to pay Paul', where one hand gives stock options to employees, while the other buys back stock to mask that dilution of investors' interest.

Author: Jacobs, Tom
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
Financial management, Personnel administration, Capital Management-Stock Repurchase, Compensation and benefits, Investor relations, Employee stock options, Stock redemption

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Biotechs for pennies?

Article Abstract:

Most of the shares of biotech companies that are sold in the United States stock markets are priced at very low rates. While purchasing shares of low stock price one should evaluate all the risks involved as the low price may indicate its vulnerability to manipulation and could also mean that the business was in danger of failure and could be delisted.

Author: Jacobs, Tom
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Securities issued, listed, Stocks, Securities, Company securities

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Bargains in the basement

Article Abstract:

The biotech company Gene Logic started in 2003 with the pharmacogenomics information business by having the contract for services to help the preclinical and clinical tests in the different drug companies. If the company is cash neutral and the stock price is nearer to cash per share it would be a much more secured investment.

Author: Jacobs, Tom
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
General services, Science & research, Research, History, Company systems management, Information management, Pharmacogenetics, Pharmacogenomics, Gene Logic Inc., Company business forecast/projection, Company forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Management, Biotechnology industry, Biotechnology industries, Company business management, Forecasts and trends, Market trend/market analysis, Stock prices
Similar abstracts:
  • Abstracts: Shine starts to fade. Lula: how long before the tears? Brazil: steady as she goes
  • Abstracts: Police cars or pay. Pensions polish. Going that extra mile
  • Abstracts: Nussbaum savages Blyth tome. PR searches for a definition. Independent PR firms flourish in '05
  • Abstracts: Asia's other tiger. War on poverty rages on
  • Abstracts: Asia's other tiger. Arrested development
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.